Optimapharm announces Ivana Waller as CEO
On Tuesday, 29th of March, Optimapharm announced that its Board of Directors has unanimously appointed Ivana Waller as Chief Executive Officer (CEO) of the Company, effective 29th March 2022.
“I have been fortunate to work for some great, soulful companies, and to learn from many incredibly inspiring leaders. The exciting challenge ahead of me now is to lead the growth strategy of Optimapharm. I am looking forward to serving my Optimapharm colleagues and our clients, and ultimately the patients in our clinical trials. I feel both elation and gratitude!”
Ivana Waller, Incoming CEO
“I wanted to say thank you for your superb support and collaboration this year. I am looking forward to work with you in 2019 as it is a pleasure to work with you and your team.”
Senior Manager Partner
Let’s talk about your pharma study needs